[go: up one dir, main page]

DE60120427D1 - Radicicol und monocillin und ihre analogen und ihre anwendungen - Google Patents

Radicicol und monocillin und ihre analogen und ihre anwendungen

Info

Publication number
DE60120427D1
DE60120427D1 DE60120427T DE60120427T DE60120427D1 DE 60120427 D1 DE60120427 D1 DE 60120427D1 DE 60120427 T DE60120427 T DE 60120427T DE 60120427 T DE60120427 T DE 60120427T DE 60120427 D1 DE60120427 D1 DE 60120427D1
Authority
DE
Germany
Prior art keywords
monocillin
radicicol
analogs
applications
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120427T
Other languages
English (en)
Inventor
J Danishefsky
M Garbaccio
K Baeschlin
J Stachel
David Solit
Neil Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Application granted granted Critical
Publication of DE60120427D1 publication Critical patent/DE60120427D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Circuits Of Receivers In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE60120427T 2000-08-25 2001-08-24 Radicicol und monocillin und ihre analogen und ihre anwendungen Expired - Lifetime DE60120427D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22827700P 2000-08-25 2000-08-25
US30455301P 2001-07-11 2001-07-11
PCT/US2001/026577 WO2002016369A2 (en) 2000-08-25 2001-08-24 Novel macrocycles and uses thereof
US09/938,754 US7115651B2 (en) 2000-08-25 2001-08-24 Macrocycles and uses thereof

Publications (1)

Publication Number Publication Date
DE60120427D1 true DE60120427D1 (de) 2006-07-20

Family

ID=27397829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120427T Expired - Lifetime DE60120427D1 (de) 2000-08-25 2001-08-24 Radicicol und monocillin und ihre analogen und ihre anwendungen

Country Status (6)

Country Link
US (1) US7115651B2 (de)
EP (1) EP1315732B1 (de)
AT (1) ATE328888T1 (de)
AU (1) AU2001286768A1 (de)
DE (1) DE60120427D1 (de)
WO (1) WO2002016369A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7705120B2 (en) 2001-06-21 2010-04-27 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20050182129A1 (en) * 2002-04-17 2005-08-18 Akiko Ikeda Hair growth tonic
ES2338789T3 (es) 2003-06-18 2010-05-12 Tranzyme Pharma Inc. Antagonistas macrociclicos del receptor de motilina.
US7538224B2 (en) 2003-06-27 2009-05-26 Kyowa Hakko Kogyo Co., Ltd. Hsp90 family protein inhibitors
US20070004674A1 (en) * 2003-08-22 2007-01-04 Kyowa Hakko Kogyo Co. Ltd. Remedy for diseases associated with immunoglobulin gene translocation
US8329683B2 (en) 2006-06-02 2012-12-11 Nexgenix Pharmaceuticals, Llc Treatment of neurofibromatosis with radicicol and its derivatives
WO2008150302A1 (en) * 2007-06-04 2008-12-11 Nexgenix Pharmaceuticals Treatment of neurofibromatosis with radicicol and its derivatives
WO2008021213A1 (en) 2006-08-11 2008-02-21 Nicolas Winssinger Macrocyclic compounds useful as inhibitors of kinases and hsp90
CN101820757A (zh) 2007-06-01 2010-09-01 普林斯顿大学托管委员会 通过调节宿主细胞代谢途径治疗病毒感染
EP2173733A2 (de) 2007-06-05 2010-04-14 WINSSINGER, Nicolas Zusammensetzungen und verfahren mit analogen von radicicol a
EP2200653A2 (de) 2007-09-10 2010-06-30 University of Massachusetts Antitumorale mittel gegen mitochondrien
WO2009105755A2 (en) 2008-02-21 2009-08-27 Nexgenix Pharmaceuticals Macrocyclic prodrug compounds useful as therapeutics
KR101835253B1 (ko) * 2008-01-15 2018-03-06 유니베르시떼 드 스트라스부르 치료제로서 유용한 레조르실산 락톤의 합성
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
US20090258869A1 (en) * 2008-02-08 2009-10-15 The Regents Of The University Of California Methods and compounds for treatment or prevention of substance-related disorders
US8663210B2 (en) 2009-05-13 2014-03-04 Novian Health, Inc. Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
WO2016196256A2 (en) 2015-06-04 2016-12-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones
PL3658148T3 (pl) 2017-07-28 2024-10-07 Turning Point Therapeutics, Inc. Związki makrocykliczne i ich zastosowania
WO2022082108A1 (en) * 2020-10-16 2022-04-21 The Brigham And Women's Hospital, Inc. Compositions for inducing tumor immunity and reducing drug tolerance

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96016E (fr) 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
FR96046E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
US3621036A (en) * 1969-02-27 1971-11-16 Merck & Co Inc Derivatives of zearalane
BE757083A (fr) * 1970-02-16 1971-03-16 Commercial Solvents Corp Nouveaux produits a activite antibacterienne
BE757082A (fr) * 1970-02-16 1971-03-16 Commercial Solvents Corp Procede de preparation de nouveaux produits a activite antibacterienne
US3901921A (en) * 1972-04-25 1975-08-26 Commercial Solvents Corp Synthesis of zearalanes and related compounds and intermediates useful in the syntheses thereof
US4035504A (en) * 1975-05-12 1977-07-12 Imc Chemical Group, Inc. Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
US4088658A (en) * 1976-11-04 1978-05-09 Imc Chemical Group, Inc. Synthesis of dideoxyzearalane and related compounds
US4228079A (en) 1978-10-30 1980-10-14 W. R. Grace & Co. Dialkoxy monorden derivatives
US4166764A (en) * 1978-02-01 1979-09-04 W. R. Grace & Co. Production of monorden
US5650430A (en) * 1990-06-06 1997-07-22 Sankyo Company, Limited Radicicol derivatives, their preparation and their anti-tumor activity
KR920000763A (ko) 1990-06-06 1992-01-29 가와무라 요시부미 라디시콜 유도체, 그 제조방법 및 그의 항종양 활성
GB9225396D0 (en) 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds
US5731343A (en) 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
ATE194610T1 (de) * 1995-04-26 2000-07-15 Kyowa Hakko Kogyo Kk Derivate des radicicols
JPH09202781A (ja) * 1996-01-25 1997-08-05 Sankyo Co Ltd ラディシコール誘導体
KR19990076764A (ko) * 1996-10-25 1999-10-15 히라타 다다시 래디시콜 유도체
AU3534499A (en) 1998-04-24 1999-11-16 Kyowa Hakko Kogyo Co. Ltd. Radicicol derivatives
US6635671B1 (en) * 1998-12-24 2003-10-21 Novation Pharmaceuticals Inc. Compounds which affect mRNA stability and uses therefor
JP2002541255A (ja) 1999-04-09 2002-12-03 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ Her族チロシンキナーゼの分解および/または阻害方法および組成物
ATE392215T1 (de) 1999-12-22 2008-05-15 Scripps Research Inst Modulatoren und inhibitoren von angiogenese und vaskulärer durchlässigkeit

Also Published As

Publication number Publication date
ATE328888T1 (de) 2006-06-15
WO2002016369A3 (en) 2002-08-29
EP1315732A2 (de) 2003-06-04
US20020091151A1 (en) 2002-07-11
US7115651B2 (en) 2006-10-03
EP1315732B1 (de) 2006-06-07
AU2001286768A1 (en) 2002-03-04
WO2002016369A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
DE60120427D1 (de) Radicicol und monocillin und ihre analogen und ihre anwendungen
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
SE0302760D0 (sv) New compounds
DE69830504D1 (de) Antithrombotische mitteln
DK1353911T3 (da) Antivirale midler
PT1263730E (pt) Derivados amina para o tratamento de apoptose
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
MA27040A1 (fr) Nucleosides substitues en 4'
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
BG66085B1 (bg) Фенилаланинови производни
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
NO20032208D0 (no) Benzodiazepinderivater som GABA A reseptormodulatorer
DE60121461D1 (de) Kondensierte pyridoindolderivate
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
BR0105563A (pt) Derivados e análogos de galantamina
SE9901077D0 (sv) Novel use
ATE272617T1 (de) Sulfonamid-derivate
CY1108224T1 (el) Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα
SE9801494D0 (sv) Novel use
ATE308540T1 (de) Antithrombosemittel
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20051282L (no) Antitumorale analoger av lamellariner.
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
ATE328595T1 (de) Carvedilolpolymorph

Legal Events

Date Code Title Description
8332 No legal effect for de